We are live on
!
Find out more
RP
Riverbridge Partners Portfolio holdings
AUM
$3.58B
1-Year Est. Return
4.02%
This Fund
S&P 500
This Quarter
Est. Return
+8.82%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.23B
AUM Growth
+$250M
(+5%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
28.91%
Holding
145
New
10
Increased
12
Reduced
104
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$55.9M |
| 2 |
West Pharmaceutical
WST
|
+$47M |
| 3 |
Alarm.com
ALRM
|
+$45.3M |
| 4 |
Globant
GLOB
|
+$38.4M |
| 5 |
Analog Devices
ADI
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$70.1M |
| 2 |
Cognex
CGNX
|
+$62.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$42.1M |
| 4 |
Veeva Systems
VEEV
|
+$25.1M |
| 5 |
Neogen
NEOG
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.74% |
| 2 | Industrials | 21.8% |
| 3 | Healthcare | 18.73% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Consumer Staples | 6.85% |
Similar funds
BPS
VPC
WWA
SPC
U
SL
SCM
AAP
Riverbridge Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Riverbridge Partners held 145 positions worth $5.23B, up 5% from $4.98B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Riverbridge Partners's Q2 2017 filing shows 10 new, 12 increased, 104 reduced and 6 closed positions. Its largest new stake was Evolent Health: 2,322,594 shares worth $58.9M. The largest sale was ZELTIQ Aesthetics, Inc., an estimated $70.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
- Riverbridge Partners's largest Q2 2017 buy was Evolent Health: 2,322,594 shares worth $58.9M.
- Riverbridge Partners added most to Verisk Analytics in Q2 2017, an estimated $23.2M increase.
- Riverbridge Partners's biggest Q2 2017 reduction was Cognex, cutting an estimated $62.5M.
- Riverbridge Partners fully exited ZELTIQ Aesthetics, Inc. in Q2 2017, selling an estimated $70.1M.
- Riverbridge Partners's ten largest holdings make up 29% of its $5.23B portfolio in Q2 2017.
- Riverbridge Partners opened 10 new positions and closed 6 in Q2 2017.
- Riverbridge Partners's portfolio value rose 5% quarter-over-quarter to $5.23B.
Based on Riverbridge Partners's 13F filing for Q2 2017, filed 24 Jul 2017.